Oikawa, T <br/><br/>
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.  [electronic resource] 

 -  Kidney international  Jan 1997 
 - 164-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1038/ki.1997.20  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II--antagonists & inhibitors<br/>Angiotensin Receptor Antagonists<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Captopril--pharmacology<br/>Cytokines--genetics<br/>Enalapril--pharmacology<br/>Fibrin--metabolism<br/>Fibrinolysin--metabolism<br/>Fibrosis<br/>Gene Expression Regulation, Enzymologic--physiology<br/>Growth Substances--genetics<br/>Imidazoles--pharmacology<br/>In Situ Hybridization<br/>Kidney--chemistry<br/>Male<br/>Plasminogen Activator Inhibitor 1--genetics<br/>Proteinuria--drug therapy<br/>RNA, Messenger--analysis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Renal Circulation--drug effects<br/>Renin--antagonists & inhibitors<br/>Tetrazoles--pharmacology<br/>Thrombosis--drug therapy<br/>Tissue Plasminogen Activator--genetics<br/>Urokinase-Type Plasminogen Activator--genetics<br/>Vasoconstrictor Agents--antagonists & inhibitors